Make Sure You Stick With Centessa Pharmaceuticals plc ADR (CNTA). It’s Bull Time Again

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Centessa Pharmaceuticals plc ADR is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Centessa Pharmaceuticals plc ADR is $2.17B. A total of 0.57 million shares were traded on the day, compared to an average of 560.82K shares.

In the most recent transaction, Bush Tia L sold 17,813 shares of CNTA for 18.00 per share on Dec 17 ’24. After the transaction, the Chief Technology & Quality Ofc now owns 147,615 company shares. In a previous transaction on Dec 16 ’24, Bush Tia L sold 9,611 shares at 16.36 per share. CNTA shares that Chief Technology & Quality Ofc owns now total 147,615.

Among the insiders who sold shares, HUSSAIN IQBAL J disposed of 77,705 shares on Dec 16 ’24 at a per-share price of $16.39. This resulted in the General Counsel holding 125,785 shares of CNTA after the transaction. In another insider transaction, Anderson Karen M. sold 10,624 shares at $17.32 per share on Dec 17 ’24. Company shares held by the Chief People Officer now total 71,525.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, CNTA has a high of $18.97 and a low of $6.65.

As of this writing, CNTA has an earnings estimate of -$0.35 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.4.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CNTA’s latest balance sheet shows that the firm has $595.08M in Cash & Short Term Investments as of fiscal 2021. There were $75.70M in debt and $24.64M in liabilities at the time. Its Book Value Per Share was $3.79, while its Total Shareholder’s Equity was $491.55M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CNTA is Buy with a score of 5.00.

Most Popular

Related Posts